StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amphastar Pharmaceuticals (AMPH) PT Raised to $25 at Needham & Company
November 9, 2018 9:14 AM
Needham & Company analyst Serge Belanger raised the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $25.00 (from $20.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Amphastar Pharmaceuticals (AMPH) PT Raised to $21 at BMO Capital
November 9, 2018 9:02 AM
Form 10-Q Amphastar Pharmaceutical For: Sep 30
November 9, 2018 6:19 AM
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018
November 9, 2018 6:00 AM
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018
November 9, 2018 6:00 AM
Form 8-K Amphastar Pharmaceutical For: Nov 08
November 8, 2018 4:32 PM
Amphastar Pharma (AMPH) Tops Q3 EPS by 1c
November 8, 2018 4:24 PM
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018
November 8, 2018 4:10 PM
